相关实验视频
Updated: Jul 8, 2025

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
48.2K
神经皮林-1是神经生长因子引起的疼痛的共同受体
bioRxiv : the preprint server for biology
|December 18, 2023
概括
神经素-1 (NRP1) 在疼痛信号中作为神经生长因子 (NGF) 和热胺相关激酶A (TrkA) 的共同受体. 准NRP1和GIPC1为慢性疼痛治疗提供了一种新的非阿片类药物治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 疼痛研究 疼痛研究
背景情况:
- 神经生长因子 (NGF) 单克隆抗体显示出慢性疼痛的潜力,但存在安全问题.
- 在 nociceptors 中NGF介导的疼痛信号的精确机制需要进一步阐明.
研究的目的:
- 为了确定参与NGF/TrkA疼痛信号传递的共同受体.
- 调查神经皮林-1 (NRP1) 作为NGF/TrkA的共同受体的作用.
- 探索NRP1和GIPC1作为慢性疼痛的潜在治疗点.
主要方法:
- 在人类和小鼠的恶性受体中对NRP1和TrkA的同表达分析.
- 使用特定抑制剂和敲击来抑制NRP1功能.
- 过度表达研究,以评估对NGF/TrkA信号传递的影响.
- 分子建模用于预测NGF/TrkA/NRP1复杂固体测量.
- GIPC1的淘汰实验评估其在NGF引起的疼痛中的作用.
主要成果:
- 在恶性受体中,NRP1与TrkA共同表达,并充当NGF的高亲和性共受体.
- NRP1促进TrkA向血和内分泌体的转移,从而增强NGF/TrkA的信号传递.
- 在小鼠中,NRP1抑制剂和淘汰抑制NGF刺激的 nociceptor激发和疼痛行为.
- GIPC1作为适应蛋白,支NRP1和TrkA,对NGF引起的疼痛至关重要.
结论:
- NRP1是NGF/TrkA疼痛信号在 nociceptors中的关键的共同受体.
- NRP1和GIPC1是参与慢性疼痛的NGF信号通路的重要组成部分.
- 准NRP1/GIPC1复合体为慢性疼痛管理提供了一个有希望的非阿片类药物治疗策略.
更多相关视频
相关概念视频
Nociception
27.9K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.9K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Analgesia and Pain Management
628
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
628

